< Back to Article

WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study

Figure 1

Flowchart summarizing the enrolment, randomization and follow-up of patients.

Values are numbers of patients as follows: Total number of patients (Number at Tunisian site/number at French site).

doi: https://doi.org/10.1371/journal.pntd.0000432.g001